BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21519281)

  • 1. Esophageal pH monitoring with the BRAVO capsule: experience in a single tertiary medical center.
    Cabrera J; Davis M; Horn D; Pfefferkorn M; Croffie JM
    J Pediatr Gastroenterol Nutr; 2011 Oct; 53(4):404-8. PubMed ID: 21519281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy and tolerability of the Bravo catheter-free pH capsule in patients between the ages of 4 and 18 years.
    Croffie JM; Fitzgerald JF; Molleston JP; Gupta SK; Corkins MR; Pfefferkorn MD; Lim JR; Steiner SJ; Dadzie SK
    J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):559-63. PubMed ID: 18030233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oesophageal pH monitoring using the Bravo catheter-free radio capsule.
    Gillies RS; Stratford JM; Booth MI; Dehn TC
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):57-63. PubMed ID: 17206078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerability and clinical utility of the Bravo pH capsule in children.
    Lacy BE; Edwards S; Paquette L; Weiss J; Kelley ML; Ornvold K
    J Clin Gastroenterol; 2009 Jul; 43(6):514-9. PubMed ID: 19349903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Successful esophageal pH monitoring with Bravo capsule in patients with gastroesophageal reflux disease].
    Valdovinos Díaz MA; Remes Troche JM; Ruiz Aguilar JC; Schmulson MJ; Valdovinos-Andraca F
    Rev Gastroenterol Mex; 2004; 69(2):62-8. PubMed ID: 15757153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of data obtained from sedated versus unsedated wireless telemetry capsule placement: does sedation affect the results of ambulatory 48-hour pH testing?
    Belafsky PC; Godin DA; Garcia JC; Rahim N
    Laryngoscope; 2005 Jun; 115(6):1109-13. PubMed ID: 15933532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 24 Versus 48-hour bravo pH monitoring.
    Chander B; Hanley-Williams N; Deng Y; Sheth A
    J Clin Gastroenterol; 2012 Mar; 46(3):197-200. PubMed ID: 21959323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Catheter-free pH-metry using the Bravo capsule versus standard pH-metry in patients with non-erosive reflux disease (NERD)].
    Mönkemüller K; Neumann H; Fry LC; Kolfenbach S; Malfertheiner P
    Z Gastroenterol; 2009 Apr; 47(4):351-6. PubMed ID: 19358061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 48-hour wireless oesophageal pH-monitoring in children: are two days better than one?
    Gunnarsdóttir A; Stenström P; Arnbjörnsson E
    Eur J Pediatr Surg; 2007 Dec; 17(6):378-81. PubMed ID: 18072019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance, tolerability, and symptoms related to prolonged pH monitoring using the Bravo system in Mexico.
    Remes-Troche JM; Ibarra-Palomino J; Carmona-Sánchez RI; Valdovinos MA
    Am J Gastroenterol; 2005 Nov; 100(11):2382-6. PubMed ID: 16279888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonendoscopic transnasal placement of a wireless capsule for esophageal pH monitoring: feasibility, safety, and efficacy of a manometry-guided procedure.
    Marchese M; Spada C; Iacopini F; Familiari P; Shah SG; Tringali A; Costamagna G
    Endoscopy; 2006 Aug; 38(8):813-8. PubMed ID: 17001571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and tolerability of transoral Bravo capsule placement after transnasal manometry using a validated conversion factor.
    Lacy BE; O'Shana T; Hynes M; Kelley ML; Weiss JE; Paquette L; Rothstein RI
    Am J Gastroenterol; 2007 Jan; 102(1):24-32. PubMed ID: 17100980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wireless capsules for esophageal pH monitoring: are we placing them correctly?
    Doma S; Paladugu S; Parkman HP; Friedenberg FK
    Digestion; 2010; 82(1):54-9. PubMed ID: 20215751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambulatory esophageal pH monitoring by using a wireless system: a pilot study in Taiwan.
    Tu CH; Lee YC; Wang HP; Wu MS; Chiu HM; Lin JT
    Hepatogastroenterology; 2004; 51(60):1586-9. PubMed ID: 15532783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Day-to-day variability in acid reflux patterns using the BRAVO pH monitoring system.
    Ahlawat SK; Novak DJ; Williams DC; Maher KA; Barton F; Benjamin SB
    J Clin Gastroenterol; 2006 Jan; 40(1):20-4. PubMed ID: 16340628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ambulatory esophageal pH monitoring using a wireless system.
    Pandolfino JE; Richter JE; Ours T; Guardino JM; Chapman J; Kahrilas PJ
    Am J Gastroenterol; 2003 Apr; 98(4):740-9. PubMed ID: 12738450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wireless esophageal pH monitoring is better tolerated than the catheter-based technique: results from a randomized cross-over trial.
    Wenner J; Johnsson F; Johansson J; Oberg S
    Am J Gastroenterol; 2007 Feb; 102(2):239-45. PubMed ID: 17100971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRAVO wireless 48 hour pH-metric system.
    Hess T; Hahn EG; Konturek PC
    Med Sci Monit; 2009 Jan; 15(1):RA17-21. PubMed ID: 19114981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of prolonged pH measurements on the diagnosis of gastroesophageal reflux disease: 4-day wireless pH studies.
    Scarpulla G; Camilleri S; Galante P; Manganaro M; Fox M
    Am J Gastroenterol; 2007 Dec; 102(12):2642-7. PubMed ID: 17850412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of esophageal acid exposure at 1 cm and 6 cm above the squamocolumnar junction using the Bravo pH monitoring system.
    Pandolfino JE; Lee TJ; Schreiner MA; Zhang Q; Roth MP; Kahrilas PJ
    Dis Esophagus; 2006; 19(3):177-82. PubMed ID: 16722995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.